Gap closes last Oakland store after 26 years Gap Inc. is exiting the Oakland market with the closure of its last remaining store. The company has been shrinking its global footprint, closing hundreds of locations in recent years. The strategy reflects a broader t
Advanced Micro Devices reports strong quarterly growth in AI-related segments, though still trails Nvidia in market share. Advanced Micro Devices (NASDAQ: AMD) posted a 57% year-over-year increase in data center revenue, driven by rising demand for AI computing hardware. T
A Micron Technology director sold 2,000 shares between May 11 and May 15, 2026, at approximately $787 per share. Micron Technology director Steven Gomo sold 2,000 shares at around $787 each between May 11, 2026, and May 15, 2026. The transaction was part of broader insider
The hedge fund acquired 354,575 shares of ERAS, reflecting a 4.05% allocation of its U.S. equity holdings as of March 31, 2026. Acuta Capital Partners disclosed a new $4.19 million position in Erasca (NASDAQ:ERAS) in a May 15, 2026 SEC filing, purchasing 354,575 shares dur
Only 26% of U.S. adults accurately estimate Medicare covers two-thirds of retiree healthcare expenses, risking budget shortfalls. A 2025 study reveals just 26% of Americans correctly understand Medicare covers about two-thirds of retiree healthcare costs. The remaining thi
Kailera Therapeutics opens at $26 per share after IPO Kailera Therapeutics priced its initial public offering at $16 per share. The company is a potential competitor to Eli Lilly and Novo Nordisk in the obesity treatment market. The GLP-1 drug market could reach $19
Costco reported $23.92 billion in April net sales, up 13% year-over-year, as inflation-weary consumers prioritize bulk purchases over discretionary spending. Costco posted a 13% year-over-year increase in April net sales, reaching $23.92 billion, despite broader economic c
Jeffrey Stibel’s $769,000 purchase at $6.15 per share marks his first open-market buy amid a 35.2% year-over-year stock decline. LegalZoom.com (NASDAQ:LZ) CEO Jeffrey Stibel purchased 125,000 shares for approximately $769,000 on May 11, 2026, according to an SEC filing. Th
Berkshire Hathaway's cash reserves rise to $397 billion as new CEO Greg Abel deploys capital into a key Buffett-backed stock. Berkshire Hathaway CEO Greg Abel has begun investing the conglomerate’s $397 billion cash pile, purchasing shares of a stock long favored by predec
The investment firm took a new 2.68% position in Nektar Therapeutics, reflecting confidence in its 669% year-over-year stock surge. Patient Square Capital LP acquired 210,000 shares of Nektar Therapeutics (NKTR) for $11.96 million, according to an SEC filing dated May 15,
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.